Chief Scientific Officer
Current
Dec 2022 - Present
AeroLeads people directory · profile
Philip Beer Email & Phone Number
Chief Scientific Officer
at
Step Pharma
LinkedIn matched
✓ Verified July 2026
3 data sources
Profile completeness 86%
Current company
Role
Chief Scientific Officer
Location
Greater Cambridge Area, United Kingdom
Who is Philip Beer? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Philip Beer is listed as Chief Scientific Officer at Step Pharma, based in Greater Cambridge Area, United Kingdom. AeroLeads shows a matched LinkedIn profile for Philip Beer.
Philip Beer previously worked as Vice President, Head of Research and Translational Medicine at Step Pharma and Honorary Professor, Translational Medicine at Hull York Medical School (Hyms). Philip Beer holds Phd from University Of Cambridge.
Company email context
Email format at Step Pharma
This section adds company-level context without repeating Philip Beer's masked contact details.
Step Pharma
Review company-level records connected to Philip Beer before choosing the right outreach path.
Profile bio
About Philip Beer
Physician scientist and cancer biologist with expertise in early phase drug development, translational medicine and biomarker discovery. Follow me on Twitter on a thread dedicated to oncology drugs and biomarkers: @cancer_evolve
Current workplace
Philip Beer's current company
Company context helps verify the profile and gives searchers a useful next step.
23 roles
Philip Beer work experience
A career timeline built from the work history available for this profile.
Vice President, Head Of Research And Translational Medicine
Step Pharma is developing novel therapeutics that inhibit the enzyme CTP Synthase 1 (CTPS1). Our most advanced molecule, STP938, is in phase 1 development for patients with relapsed/refractory B or T cell lymphoma (NCT05463263).
Jul 2021 - Nov 2022
Honorary Professor, Translational Medicine
Undergraduate teaching at the Medical School; supporting academic research as an honorary member of the York Biomedical Research Institute, University of York.
Chair, Genomics Working Group
Clinical Cancer Genomics
Delivery of the 100,000 genomes project cancer samples (East of England & the North East).
Sep 2018 - Mar 2020
Jun 2017 - Sep 2018
Founder And Chair
Making precision oncology a reality for those living with cancer.
Clinical Cancer Genomics
International Cancer Genome Consortium's next generation project- Accelerating Research in Genomic Oncology.
Head Of Research And Translational Medicine
Karus Therapeutics Limited
Therapeutic development in oncology and other indications.
Apr 2020 - Jun 2021
Head Of Translational Medicine
Karus Therapeutics Limited
Preclinical development | Clinical trial pharmacodynamics | Exploratory & translational studies.
Jul 2017 - Apr 2020
Head Of Genomic Strategy
Driving oncology drug discovery through translational reserarch and biomarker discover.
Oct 2016 - Jun 2021
Uk Medical Director
Genomic data interpretation and clinical support.
Jan 2018 - Mar 2021
Head Of Translational Medicine
Unlocking clinical utility of AI-led genomic analysis and interpretation.
Jul 2019 - Sep 2020
Medical Advisor
Cure Forward
Innovative patient-centred approach to increase & expedite trial enrolment for individuals with cancer. A project that was ahead of its time, and has now ceased operations due to financial difficulties. Personal contributions included patient profile construction & clinical trial selection (>200 individuals), actionability analysis of molecular profiles (somatic & germline) and mapping of clinical trial landscapes.
Nov 2016 - Jun 2017
Director Of Medical Genomics
Leadership of medical/scientific team at erstwhile cancer genomics start-up, working in partnership with the Sanger Institute and collaborators across the UK and Europe.
Feb 2014 - Feb 2016
Post-Doctoral Fellow
Research with Dr Connie Eaves at the Terry Fox Laboratory focussed on the generation of improved in vitro and in vivo models of leukaemia through the genetic manipulation of normal and pre-leukaemic human blood cells.
Apr 2010 - Mar 2014
Clinical Lecturer
Translational research and patient care in the Department of Haematology at Addenbrooke's Hospital.
Jan 2009 - Mar 2010
Clinical Research Fellow
Research with Prof. Tony Green focussed on the study of genotype-phenotype correlations in human leukaemia.
Sep 2005 - Dec 2008
Specialist Registrar
Specialist training in clinical and laboratory haematology at Hammersmith, Charing Cross & St Mary’s Hospitals.
Jan 2001 - Aug 2005
4 education records
Philip Beer education
Phd
University Of Cambridge
Bmedsci; Bm, Bs
University Of Nottingham
Frcpath
Royal College Of Pathologists
Mrcp
Royal College Of Physicians
FAQ
Frequently asked questions about Philip Beer
Quick answers generated from the profile data available on this page.
What company does Philip Beer work for?
Philip Beer works for Step Pharma.
What is Philip Beer's role at Step Pharma?
Philip Beer is listed as Chief Scientific Officer at Step Pharma.
Where is Philip Beer based?
Philip Beer is based in Greater Cambridge Area, United Kingdom while working with Step Pharma.
What companies has Philip Beer worked for?
Philip Beer has worked for Step Pharma, Hull York Medical School (Hyms), British In Vitro Diagnostics Association (Bivda), Nhs, and Gabriel Precision Oncology.
How can I contact Philip Beer?
You can use AeroLeads to view verified contact signals for Philip Beer at Step Pharma, including work email, phone, and LinkedIn data when available.
What schools did Philip Beer attend?
Philip Beer holds Phd from University Of Cambridge.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial